poisar

Stocks · News reference

8-K filing — ORAMED PHARMACEUTICALS INC. (ORMP)

SEC EDGARSEC EDGAR

Filed: 2026-06-30 AccNo: 0001213900-26-073709 Size: 347 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaPrnewswire

    Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes

    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced it will be added to the Russell 2000® and Russell 3000® indexes following the 2026 semi-annual reconstitution, effective June 29, 2026. The inclusion is based on the company's market capitalization ranking as of April 30, 2026, and will provide automatic inclusion in appropriate growth and value style indexes.